These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 6878993)

  • 41. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. USA supports measles elimination.
    EPI Newsl; 1996 Jun; 18(3):1. PubMed ID: 12347182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of measles in Israel: short- and long-term intervention strategies.
    Tulchinsky TH
    Isr J Med Sci; 1991 Jan; 27(1):22-9. PubMed ID: 1995496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measles eradication: experience in the Americas.
    de Quadros CA; Hersh BS; Nogueira AC; Carrasco PA; da Silveira CM
    Bull World Health Organ; 1998; 76 Suppl 2(Suppl 2):47-52. PubMed ID: 10063674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two doses of measles vaccine reduce measles dealths.
    van den Ent M; Gupta SK; Hoekstra E
    Indian Pediatr; 2009 Nov; 46(11):933-8. PubMed ID: 19955576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.
    Verma R; Khanna P; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Oct; 7(10):1109-11. PubMed ID: 22238787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating the Number of Measles-Susceptible Children and Adolescents in the United States Using Data From the National Immunization Survey-Teen (NIS-Teen).
    Bednarczyk RA; Orenstein WA; Omer SB
    Am J Epidemiol; 2016 Jul; 184(2):148-56. PubMed ID: 27338281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measles eradication in the Americas: progress to date.
    de Quadros CA; Izurieta H; Venczel L; Carrasco P
    J Infect Dis; 2004 May; 189 Suppl 1():S227-35. PubMed ID: 15106116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of measles eradication activities on routine immunization services and health systems in Bangladesh.
    Koehlmoos TP; Uddin J; Sarma H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S90-7. PubMed ID: 21666219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization against measles by aerosol.
    Sabin AB
    Rev Infect Dis; 1983; 5(3):514-23. PubMed ID: 6348918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of the measles vaccination program in Costa Rica.
    León de Coto EM
    Rev Infect Dis; 1983; 5(3):588-91. PubMed ID: 6879020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles update.
    EPI Newsl; 1998 Aug; 20(4):1. PubMed ID: 12348763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measles vaccination in an increasingly immunized and developed world.
    Hayman DTS
    Hum Vaccin Immunother; 2019; 15(1):28-33. PubMed ID: 30156949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
    Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
    Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [What is wrong with the measles vaccine in Mexico? Study of an epidemic outbrake of measles].
    Sánchez Y; Alvarez PF; Saldaña E; Salomón A; Ruiz-Gómez J; Muñoz O
    Bol Med Hosp Infant Mex; 1977; 34(2):291-7. PubMed ID: 843401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
    Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
    J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First 5 years of measles elimination in southern Africa: 1996-2000.
    Biellik R; Madema S; Taole A; Kutsulukuta A; Allies E; Eggers R; Ngcobo N; Nxumalo M; Shearley A; Mabuzane E; Kufa E; Okwo-Bele JM
    Lancet; 2002 May; 359(9317):1564-8. PubMed ID: 12047966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.